FREE Account Opening + No Clearing Fees
Loading...

Infinium Pharmachem IPO vs Maiden Forgings IPO

Comparision between Infinium Pharmachem IPO and Maiden Forgings IPO.

IPO Details

Infinium Pharmachem IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Maiden Forgings IPO is a SME Book Built Issue proposed to list at BSE SME.

  Infinium Pharmachem IPO Maiden Forgings IPO
Logo Infinium Pharmachem IPO Logo Maiden Forgings IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Fixed Price Issue Book Built Issue
Listing At NSE SME BSE SME
Lead Managers Swastika Investmart Ltd Share India Capital Services Private Limited
Registrar Bigshare Services Pvt Ltd Maashitla Securities Private Limited
Market Maker Swastika Investmart Limited Share India Securities Limited
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Infinium Pharmachem IPO is up to ₹25.26 Cr whereas the issue size of the Maiden Forgings IPO is up to ₹23.84 Cr. The final issue price of Infinium Pharmachem IPO is ₹135.00 per share and of Maiden Forgings IPO is ₹63.00 per share.

  Infinium Pharmachem IPO Maiden Forgings IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹60.00 per share
Issue Price (Upper) ₹63.00 per share
Issue Price (Final) ₹135.00 per share ₹63.00 per share
Discount (Retail)
Discount (Employee) ₹13.50 per share
Market Lot Size 1000 shares 2000 shares
Fresh Issue Size 18,75,000 shares 37,84,000 shares
Fresh Issue Size (Amount) up to ₹25.26 Cr up to ₹23.84 Cr
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 18,75,000 shares 37,84,000 shares
Issue Size Total (Amount) up to ₹25.26 Cr up to ₹23.84 Cr

IPO Timetable

Infinium Pharmachem IPO opens on Mar 31, 2023, while Maiden Forgings IPO opens on Mar 23, 2023. The closing date of Infinium Pharmachem IPO and Maiden Forgings IPO is Apr 05, 2023, and Mar 27, 2023, respectively.

  Infinium Pharmachem IPO Maiden Forgings IPO
Anchor Bid Date Mar 22, 2023
Issue Open Mar 31, 2023 Mar 23, 2023
Issue Close Apr 05, 2023 Mar 27, 2023
Basis Of Allotment (Tentative) Apr 11, 2023 Mar 31, 2023
Initiation of Refunds (Tentative) Apr 12, 2023 Apr 03, 2023
Credit of Share (Tentative) Apr 13, 2023 Apr 05, 2023
Listing date (Tentative) Apr 17, 2023 Apr 06, 2023
Anchor Lockin End date 1 May 11, 2023 Apr 30, 2023
Anchor Lockin End date 2 Jul 10, 2023 Jun 29, 2023

Financials

Infinium Pharmachem IPO P/E ratio is 7.83, as compared to Maiden Forgings IPO P/E ratio of 8.38.

  Infinium Pharmachem IPO Maiden Forgings IPO
Financial
Infinium Pharmachem Private Limited Financial Information (Restated Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthTotal Borrowing
31-Mar-202,244.603,941.6493.40424.74566.17
31-Mar-213,418.277,115.37272.48702.32579.47
31-Mar-225,899.9510,005.25610.641,310.221,385.01
30-Sep-227,075.717,985.39551.011,855.771,614.71
Amount in ₹ Lakhs
Maiden Forgings Limited Financial Information (Restated Standalone)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31-Mar-209,890.0520,440.37165.952,136.921,672.025,788.13
31-Mar-2110,484.2519,937.49168.942,899.112,377.715,428.93
31-Mar-2211,014.2321,083.72213.943,113.052,591.656,170.75
31-Dec-2212,595.6916,381.04801.513,914.562,871.766,525.17
Amount in ₹ Lakhs
Promoter Shareholding (Pre-Issue) 100% 100%
Promoter Shareholding (Post-Issue) 73.05% 73.37%
P/E Ratio 7.83 8.38
Market Cap ₹93.93 Cr. ₹89.54 Cr.
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Infinium Pharmachem IPO retail investors (RII) are offered 9,37,500 shares while in Maiden Forgings IPO retail investors are offered 9,37,500 shares. Qualified institutional buyers (QIB) are offered 0 shares in Infinium Pharmachem IPO and 3,60,000 shares in Maiden Forgings IPO.

  Infinium Pharmachem IPO Maiden Forgings IPO
Anchor Investor Reserveration
Market Maker Reserveration 94,000 shares 1,90,000 shares
QIB 0 shares 3,60,000 shares
NII 9,37,500 shares 9,70,000 shares
RII 9,37,500 shares 22,64,000 shares
Employee 0 shares 0 shares
Others
Total 18,75,000 shares 37,84,000 shares

Bids Received (Subscription)

Infinium Pharmachem IPO subscribed 1.84x in total, whereas Maiden Forgings IPO subscribed 1.20x.

  Infinium Pharmachem IPO Maiden Forgings IPO
QIB (times) 1.00x
NII (times) 1.80x 1.42x
Big NII (times)
Small NII (times)
RII (times) 1.86x 1.12x
Employee (times)
Other (times)
Total (times) 1.84x 1.20x

Comments

Add a public comment...